Detection by fluorescence of pituitary neuroendocrine tumour (PitNET) tissue during endoscopic transsphenoidal surgery using bevacizumab-800CW (DEPARTURE trial): study protocol for a non-randomised, non-blinded, single centre, feasibility and dose-finding trial
Guardado en:
Autores principales: | Wouter B Nagengast, J Marc C van Dijk, André P van Beek, Rob A Vergeer, Mark R Postma, Iris Schmidt, Astrid GW Korsten-Meijer, Robert A Feijen, Schelto Kruijff, Wilfred F A den Dunnen, Jos M A Kuijlen, Gerrit van den Berg |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
BMJ Publishing Group
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/6890a406da9240c0a16543be3043e210 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Feasibility of ex vivo fluorescence imaging of angiogenesis in (non-) culprit human carotid atherosclerotic plaques using bevacizumab-800CW
por: Lydian A. Huisman, et al.
Publicado: (2021) -
Partial oral antibiotic treatment for bacterial brain abscess: an open-label randomized non-inferiority trial (ORAL)
por: Jacob Bodilsen, et al.
Publicado: (2021) -
Letters of C.W. Scott
Publicado: (2017) -
Perioperative management of endoscopic transsphenoidal pituitary surgery
por: Martin Hanson, et al.
Publicado: (2020) -
Trial by trial EEG based BCI for distress versus non distress classification in individuals with ASD
por: Safaa Eldeeb, et al.
Publicado: (2021)